- 2020
- Press releases - 26.05.2020
Inclusions in the hydroxychloroquine group of the Discovery trial are suspended.
Les inclusions dans le groupe hydroxychloroquine de l’essai Discovery sont suspendues depuis dimanche 24 mai.
- Press releases - 20.05.2020
SARS-CoV-2: Will Summer Really Mean the End of It?
Will SARS-CoV-2 die out with the arrival of summer? With the current lifting of lockdown restrictions, some are hoping that the warm weather will herald a decrease in the R0, as is the case with other viruses whose transmission is better documented, such as those of seasonal influenza.
- Press releases - 19.05.2020
Milestone: Inserm’s commitment to the fight against the Covid-19 pandemic
First identified in the central Chinese city of Wuhan in December 2019, the novel SARS-CoV-2 coronavirus has rapidly spread across the world, leading to the most serious pandemic in recent history.
- Press releases - 12.05.2020
Blood Stem Cell Immune Memory: A New Research Avenue in COVID-19
Blood stem cells have a surprising ability. In addition to ensuring the continuous renewal of blood cells, they keep track of past infections so that faster and more effective immune responses can be triggered in the future.
- Press releases - 27.04.2020
EpiCOV: Population Immune Status Data to Guide Public Decision-Making
Driven by Inserm and the Directorate for Research, Studies, Assessment and Statistics (DREES) of France’s Ministry of Solidarity and Health, in conjunction with their partners (National Institute of Statistics and Economic Studies [INSEE], Public Health Agency, National Center for Scientific Research [CNRS], National Institute for Demographic Studies [INED], Université Paris-Saclay), EpiCOV is a large-scale epidemiological study based on a major statistical survey. It is proposing global and scientifically reliable mapping of population immune status and dynamics across the French territory through the collection of biological samples paired with questionnaires.
- Press releases - 27.04.2020
The StopCovid project-team and the ecosystem of contributors are working together to develop a mobile contact tracing app for France
Inria, ANSSI, Capgemini, Dassault Systèmes, Inserm, Lunabee Studio, Orange, Santé Publique France and Withings create the StopCovid project team in order to structure and strengthen their contribution to the government project to set up a mobile contact tracing application (StopCovid). The purpose of this project is to provide the French health authorities with a complementary digital tool to help manage the sanitary emergency against Covid-19.
- Press releases - 24.04.2020
Malaria: Vaccine clinical trial for Pregnant Women yields promising results
Malaria infection during pregnancy represents a major public health problem in the regions endemic for the disease, substantially increasing the risks to mothers and their unborn children. For newborns, malaria is linked to low birth weight and an excess risk of mortality. To protect this population, a team of researchers is developing a vaccine at the French National Institute of Blood Transfusion (INTS).
- What's on? - 24.04.2020
Malaria: Vaccine clinical trial for Pregnant Women yields promising results
Malaria infection during pregnancy represents a major public health problem in the regions endemic for the disease, substantially increasing the risks to mothers and their unborn children. For newborns, malaria is linked to low birth weight and an excess risk of mortality. To protect this population, a team of researchers from Inserm and Université de […]
- Press releases - 22.04.2020
Inserm’s commitment to the fight against the Covid-19 pandemic
Inserm has played a leading role in the French and international research spheres, rallying its many experts in subjects related to fundamental research, therapeutic research, and modelling. Participating also in France’s solidarity effort, the Institute has taken action to distribute tens of thousands of masks, gloves, gowns, shoe covers and reagents to medical teams working in the nation’s hospitals.
- Press releases - 10.04.2020
COVID-19 and Confinement: A Large-Scale French Survey of Social Challenges and Health
For a deeper insight into the social and epidemiological challenges posed by the exceptional prevention measures taken in response to the COVID-19 pandemic – particularly confinement – a multidisciplinary group of researchers has joined forces with Inserm and the Public Health Agency to launch a survey of around 200,000 participants from five major French cohorts.